Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma

Publisher： Karger

E-ISSN： 1421-9794|62|3|187-191

ISSN： 0009-3157

Source： Chemotherapy, Vol.62, Iss.3, 2017-03, pp. : 187-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma

By Hammouda Nada E. Salah El-Din Manal A. El-Shishtawy Mamdouh M. El-Gayar Amal M.

Scientia Pharmaceutica, Vol. 85, Iss. 1, 2017-03 ,pp. : 9-9

MDPI

Access to resources Recommend Favorite

Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications

By Lenz Georg

Cancers, Vol. 7, Iss. 2, 2015-05 ,pp. : 811-822

MDPI

Access to resources Recommend Favorite

Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma

By Yan Fengting Gopal Ajay K. Graf Solomon A.

Pharmaceuticals, Vol. 10, Iss. 1, 2017-03 ,pp. : 28-28

MDPI

Access to resources Recommend Favorite

miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients

By Troppan Katharina Wenzl Kerstin Pichler Martin Pursche Beata Schwarzenbacher Daniela Feichtinger Julia Thallinger Gerhard G. Beham-Schmid Christine Neumeister Peter Deutsch Alexander

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 18077-18095

MDPI

Access to resources Recommend Favorite

Inhibition of the PI3K/Akt/mTOR Signaling Pathway in Diffuse Large B-Cell Lymphoma: Current Knowledge and Clinical Significance

By Majchrzak Agata Witkowska Magdalena Smolewski Piotr

Molecules, Vol. 19, Iss. 9, 2014-09 ,pp. : 14304-14315

MDPI

Access to resources Recommend Favorite